glp 1 drugs and levothyroxine Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality TSH Levels Weight Loss GLP-1 Drugs and

Description

DOI: 10.1056/NEJMe2409972

Per the TrumpRx site, it is expected to launch in January 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as nonalcoholic fatty liver disease (NAFLD), has seen its global prevalence surge from 25% between 1990 and 2006 to 38% between 2016 and 2019

Nidorf SM, Fiolet ATL, Mosterd A et al (2020) Colchicine in patients with chronic coronary disease

Retatrutide 10mg is used to study its effects on weight loss, glucose control, and metabolic dysfunction in controlled laboratory settings, focusing on its triple GLP-1/GIP/Glucagon receptor agonist properties